US6204431B1
(en)
*
|
1994-03-09 |
2001-03-20 |
Abbott Laboratories |
Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
|
WO1997028258A1
(en)
*
|
1996-01-30 |
1997-08-07 |
The National Institutes Of Health |
Cells expressing both human cd4 and cxcr4
|
US5906982A
(en)
*
|
1997-03-31 |
1999-05-25 |
Abbott Laboratories |
Nutritional formulations containing Lacto-N-neoTetraose
|
US5968809A
(en)
|
1997-04-11 |
1999-10-19 |
Abbot Laboratories |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
|
US6323008B1
(en)
*
|
1997-08-14 |
2001-11-27 |
Neose Technologies, Inc. |
Methods for producing sialyloligosaccharides in a dairy source
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US6699672B1
(en)
*
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
GB9807464D0
(en)
*
|
1998-04-07 |
1998-06-10 |
Pharming Bv |
Purification of human acid µ-glucosidase
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
US6677145B2
(en)
|
1998-09-02 |
2004-01-13 |
Abbott Laboratories |
Elongase genes and uses thereof
|
US20030163845A1
(en)
*
|
1998-09-02 |
2003-08-28 |
Pradip Mukerji |
Elongase genes and uses thereof
|
EP1157118A4
(en)
*
|
1999-03-01 |
2002-07-17 |
Insight Strategy & Marketing |
POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
|
US6329170B1
(en)
*
|
1999-04-23 |
2001-12-11 |
Northwest Hospital |
Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
|
US7070970B2
(en)
|
1999-08-23 |
2006-07-04 |
Abbott Laboratories |
Elongase genes and uses thereof
|
ATE466882T1
(de)
|
2000-01-12 |
2010-05-15 |
Univ Yale |
Nogo rezeptor-vermittelte blockade des axonalen wachstums
|
EP1197550A3
(en)
*
|
2000-08-25 |
2002-11-20 |
Pfizer Products Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
US20020073441A1
(en)
|
2000-12-13 |
2002-06-13 |
Ross Brian D. |
Compositions and methods for detecting proteolytic activity
|
EP1392823B1
(en)
|
2001-01-25 |
2011-11-30 |
Abbott Laboratories |
Desaturase genes and uses thereof
|
US6635451B2
(en)
*
|
2001-01-25 |
2003-10-21 |
Abbott Laboratories |
Desaturase genes and uses thereof
|
US20040086981A1
(en)
*
|
2001-03-14 |
2004-05-06 |
Toshinori Sato |
Process for producing oligosaccharide chains
|
CA2458512A1
(en)
|
2001-08-24 |
2003-03-06 |
Kyowa Hakko Kogyo Co., Ltd. |
.alpha.-1,2-fucosyl transferase and dna encoding the same
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US7211656B2
(en)
*
|
2002-01-30 |
2007-05-01 |
Abbott Laboratories |
Desaturase genes, enzymes encoded thereby, and uses thereof
|
CA2481411C
(en)
|
2002-04-19 |
2016-06-14 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
WO2004050847A2
(en)
*
|
2002-11-27 |
2004-06-17 |
Gtc Biotherapeutics, Inc. |
Modified antibodies stably produced in milk and methods of producing same
|
US20040231010A1
(en)
*
|
2003-01-09 |
2004-11-18 |
Murray James D. |
Lysozyme transgenic ungulates
|
CA2920416A1
(en)
|
2003-03-06 |
2004-10-28 |
Basf Enzymes Llc |
Amylases, nucleic acids encoding them and methods for making and using them
|
CA2515583C
(en)
|
2003-03-07 |
2015-07-14 |
Diversa Corporation |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
ES2598037T3
(es)
|
2003-04-04 |
2017-01-24 |
Basf Enzymes Llc |
Pectato liasas, ácidos nucleicos que las codifican y métodos para su preparación y uso
|
WO2004108065A2
(en)
*
|
2003-06-09 |
2004-12-16 |
Insight Biopharmaceuticals Ltd. |
Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
|
ES2401795T3
(es)
|
2003-07-02 |
2013-04-24 |
Syngenta Participations Ag |
Glucanasas, ácidos nucleicos que las codifican y métodos para eleborarlas y utilizarlas
|
EP1668113B1
(en)
|
2003-08-11 |
2013-06-19 |
Verenium Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
JP5236189B2
(ja)
|
2003-12-05 |
2013-07-17 |
チルドレンズ ホスピタル メディカル センター |
オリゴ糖組成物および感染症の治療における該組成物の使用
|
US7871793B2
(en)
*
|
2004-02-20 |
2011-01-18 |
Burnham Institute For Medical Research |
Antimicrobial carbohydrates and methods of using same
|
JP2008505619A
(ja)
|
2004-06-16 |
2008-02-28 |
ヴェレニウム コーポレイション |
葉緑素を酵素的に脱色するための組成物及び方法
|
US7456270B2
(en)
*
|
2004-09-01 |
2008-11-25 |
Abbott Laboratories |
Δ6-desaturase genes and uses thereof
|
US20080019905A9
(en)
*
|
2005-02-18 |
2008-01-24 |
Strome Scott E |
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
CA2614769A1
(en)
|
2005-03-10 |
2006-09-21 |
Verenium Corporation |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
US8426184B2
(en)
|
2005-03-15 |
2013-04-23 |
Bp Corporation North America |
Cellulases, nucleic acids encoding them and methods for making and using them
|
US7400417B2
(en)
*
|
2005-05-23 |
2008-07-15 |
Federal Mogul World Wide, Inc. |
Diffraction method for measuring thickness of a workpart
|
EP1945666B1
(en)
*
|
2005-10-21 |
2013-03-27 |
GTC Biotherapeutics, Inc. |
Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
|
EP2216403A3
(en)
|
2006-02-02 |
2010-11-24 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
EP2420570B1
(en)
|
2006-02-10 |
2013-12-04 |
Verenium Corporation |
Arabinofuranosidase enzymes, nucleic acids encoding them and methods for making and using them
|
EP3406621A1
(en)
|
2006-02-14 |
2018-11-28 |
BP Corporation North America Inc. |
Xylanases, nucleic acids encoding them and methods for making and using them
|
ES2383767T3
(es)
|
2006-03-07 |
2012-06-26 |
Verenium Corporation |
Aldolasas, ácidos nucleicos que las codifican y métodos para producir y usar las mismas
|
JP5441417B2
(ja)
|
2006-03-07 |
2014-03-12 |
カーギル・インコーポレイテッド |
アルドース、それをコードする核酸、ならびにそれを生成および使用する方法
|
CN106222185B
(zh)
|
2006-08-04 |
2021-12-03 |
维莱尼姆公司 |
葡聚糖酶、编码它们的核酸及制备和使用它们的方法
|
MX2009003034A
(es)
|
2006-09-21 |
2009-11-18 |
Verenium Corp |
Fosfolipasas, acidos nucleicos que las codifican, y metodos de hacerlas y usarlas.
|
EP2617814B1
(en)
|
2006-09-21 |
2015-11-18 |
BASF Enzymes LLC |
Phytases, nucleic acids encoding them and methods for making and using them
|
BRPI0719449A2
(pt)
|
2006-12-21 |
2017-06-20 |
Syngenta Participations Ag |
molécula de ácido nucléico isolada, sintética ou recombinante, polipeptídeo isolado, planta ou parte de planta, eículo de clonagem que compreende um ácido nucléico, cassete de expressão que compreende uma molécula de ácido nucléico e método para hidrolisar um polissacarídeo, oligossacarídeo ou amido
|
JP5766947B2
(ja)
|
2007-09-07 |
2015-08-19 |
チルドレンズ ホスピタル メディカル センター |
臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用
|
EP2708602B1
(en)
|
2007-10-03 |
2019-02-27 |
BP Corporation North America Inc. |
Xylanases, nucleic acids encoding them and methods for making and using them
|
EP2217721A4
(en)
*
|
2007-10-29 |
2013-01-09 |
Univ California |
GENE THERAPY FOR OSTEOARTHRITIS
|
AU2008347234B2
(en)
|
2008-01-03 |
2015-05-28 |
Basf Enzymes Llc |
Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
|
WO2009088753A1
(en)
|
2008-01-03 |
2009-07-16 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
US8030471B2
(en)
*
|
2008-03-06 |
2011-10-04 |
Abbott Laboratories |
Plasmodium malariae and Plasmodium ovale genes and uses thereof
|
US8268981B2
(en)
*
|
2008-03-06 |
2012-09-18 |
Abbott Laboratories |
Plasmodium malariae and plasmodium ovale genes and uses thereof
|
US20110229460A1
(en)
*
|
2008-05-01 |
2011-09-22 |
Gtc Biotherapeutics, Inc. |
anti-cd137 antibody as an agent in the treatment of inflammatory conditions
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US20110269233A1
(en)
|
2008-09-15 |
2011-11-03 |
Laetitia Malphettes |
Compositions and methods for regulating cell osmolarity
|
JP5723281B2
(ja)
*
|
2008-10-06 |
2015-05-27 |
アボット・ラボラトリーズAbbott Laboratories |
デルタ−8デサチュラーゼ遺伝子、それによってコードされる酵素およびそれらの使用
|
US8063193B2
(en)
|
2009-03-27 |
2011-11-22 |
Abbott Laboratories |
Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
|
NZ596099A
(en)
*
|
2009-04-13 |
2013-11-29 |
Childrens Hosp Medical Center |
Milk oligosaccharide compositions and use thereof in treating infection in animals
|
AU2010249500B2
(en)
|
2009-05-21 |
2016-03-24 |
Basf Enzymes Llc |
Phytases, nucleic acids encoding them and methods for making and using them
|
CA2766798A1
(en)
|
2009-06-30 |
2011-01-06 |
Abbott Laboratories |
Markers of xmrv infection and uses thereof
|
DK2451462T3
(en)
|
2009-07-06 |
2017-12-11 |
Children's Hospital Medical Center |
Inhibition of inflammation with milk oligosaccharides
|
US8188335B2
(en)
|
2009-07-17 |
2012-05-29 |
Abbott Laboratories |
Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
CN103391783A
(zh)
|
2010-12-31 |
2013-11-13 |
雅培制药有限公司 |
使用人乳寡糖改善呼吸道健康的方法
|
EP3338784B1
(en)
*
|
2010-12-31 |
2020-07-22 |
Abbott Laboratories |
Human milk oligosaccharides for modulating inflammation
|
NZ612472A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
MY166945A
(en)
|
2010-12-31 |
2018-07-25 |
Abbott Lab |
Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
|
US9662379B2
(en)
|
2011-12-02 |
2017-05-30 |
Rhode Island Hospital |
Vaccine for falciparum malaria
|
EA201590488A1
(ru)
*
|
2012-10-12 |
2015-09-30 |
Гликоваксин Аг |
Способы модификации клеток-хозяев
|
KR20160002713A
(ko)
|
2013-02-13 |
2016-01-08 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
고도로 갈락토실화된 항-tnf-알파 항체 및 이의 용도
|
AR094778A1
(es)
*
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Proteínas con glicosilación modificada y métodos para producirlas
|
WO2014130789A1
(en)
|
2013-02-21 |
2014-08-28 |
Children's Hospital Medical Center |
Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
|
US10857167B2
(en)
|
2015-04-28 |
2020-12-08 |
Children's Hospital Medical Center |
Use of oligosaccharide compositions to enhance weight gain
|
WO2020014307A1
(en)
|
2018-07-11 |
2020-01-16 |
Ohio University |
Peptide-based inhibitors of growth hormone action and methods of the thereof
|